Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model
Huang, T T, Hlavaty, J, Ostertag, D, Espinoza, F L, Martin, B, Petznek, H, Rodriguez-Aguirre, M, Ibañez, C E, Kasahara, N, Gunzburg, W, Gruber, H E, Pertschuk, D, Jolly, D J, Robbins, J M
Published in Cancer gene therapy (01.10.2013)
Published in Cancer gene therapy (01.10.2013)
Get full text
Journal Article
Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model
Yin, D, Zhai, Y, Gruber, H E, Ibanez, C E, Robbins, J M, Kells, A P, Kasahara, N, Forsayeth, J, Jolly, D J, Bankiewicz, K S
Published in Cancer gene therapy (01.06.2013)
Published in Cancer gene therapy (01.06.2013)
Get full text
Journal Article
PC3 - 151 Toca 5: A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Patients Undergoing Planned Resection for Recurrent Glioblastoma (GBM) or Anaplastic Astrocytoma (AA) (NCT02414165)
Zadeh, G., Bota, D., Cachia, D., Landolfi, J., Schiff, D., Vogelbaum, M.A., Walbert, T., Tran, D., Chu, A., Das, A., Jolly, D.J., Ibañez, C.E., Ostertag, D., Sully, S., Cloughesy, T.F.
Published in Canadian journal of neurological sciences (01.10.2016)
Published in Canadian journal of neurological sciences (01.10.2016)
Get full text
Journal Article